user

Reversal of Donor Hepatitis C Virus-Related Mesangial Proliferative GN in a Kidney Transplant Recipient

被引：1
|
作者：
Khairallah, Pascale [1 ]
Kudose, Satoru [2 ]
Morris, Heather K. [1 ]
Ratner, Lloyd E. [3 ]
Mohan, Sumit [1 ,4 ,5 ]
Radhakrishnan, Jai [1 ]
Chang, Jae-Hyung [1 ]
机构：
[1] Columbia Univ Vagelos Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA
[2] Columbia Univ Vagelos Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY USA
[3] Columbia Univ Vagelos Coll Phys & Surg, Dept Surg, New York, NY USA
[4] Columbia Univ Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA
[5] Columbia Univ Renal Epidemiol Grp, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 31卷 / 10期
关键词：
kidney transplantation; hepatitis; glomerulonephritis; transplant outcomes;
D O I：
10.1681/ASN.2020060820
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2246 / 2249
页数：4
相关论文
共 50 条
  • [21] Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient
    Saberi, Behnam
    Hamilton, James P.
    Durand, Christine M.
    Li, Zhiping
    Philosophe, Benjamin
    Cameron, Andrew M.
    Sulkowski, Mark S.
    Gurakar, Ahmet
    LIVER TRANSPLANTATION, 2018, 24 (01) : 140 - 143
  • [22] Analysis of the effects of donor and recipient hepatitis C infection on kidney transplant outcomes in the United States
    Qing Yuan
    Shanjuan Hong
    Gregory Leya
    Eve Roth
    Georgios Tsoulfas
    WW Williams
    Joren C Madsen
    Nahel Elias
    World Journal of Transplantation, 2023, (02) : 44 - 57
  • [23] The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience
    Singh, Neeraj
    Neidlinger, Nikole
    Djamali, Arjang
    Leverson, Glen
    Voss, Barbara
    Sollinger, Hans W.
    Pirsch, John D.
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : 684 - 693
  • [24] Management of Hepatitis C Virus-Related Arthritis
    Eli Zuckerman
    Daniel Yeshurun
    Itzhak Rosner
    BioDrugs, 2001, 15 : 573 - 584
  • [25] Hepatitis B and C virus-related carcinogenesis
    Fung, J.
    Lai, C. -L.
    Yuen, M. -F.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (11) : 964 - 970
  • [26] Hepatitis C virus-related cryoglobulinemic vasculitis
    Mazzaro, Cesare
    Mauro, Endri
    Ermacora, Anna
    Doretto, Paolo
    Fumagalli, Silvia
    Tonizzo, Maurizio
    Toffolutti, Federica
    Gattei, Valter
    MINERVA MEDICA, 2021, 112 (02) : 175 - 187
  • [27] Reversibility of hepatitis C virus-related cirrhosis
    Pol, S
    Carnot, F
    Nalpas, B
    Lagneau, JL
    Fontaine, H
    Serpaggi, J
    Serfaty, L
    Bedossa, P
    Bréchot, C
    HUMAN PATHOLOGY, 2004, 35 (01) : 107 - 112
  • [28] Hepatitis C Virus-Related Cryoglobulinemic Vasculitis
    Gjeorgjievski, Mihajlo
    Orosey, Molly
    Cappell, Mitchell S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (08) : E81 - E81
  • [29] Management of hepatitis C virus-related arthritis
    Palazzi, C
    Olivieri, I
    Cacciatore, P
    Pennese, E
    D'Amico, E
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (01) : 27 - 34
  • [30] Management of hepatitis C virus-related arthritis
    Zuckerman, E
    Yeshurun, D
    Rosner, I
    BIODRUGS, 2001, 15 (09) : 573 - 584
12345